IKS Health's innovative solution orchestrates a roll out of critical operations functions into a unified and efficient connected workflow
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
BIL also holds an option to increase its equity stake by an additional 15%
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Subscribe To Our Newsletter & Stay Updated
